FDA Lacks Timeliness In Reviewing Drug Ads: Report
The U.S. Food and Drug Administration is taking too long to warn pharmaceutical companies about false and misleading advertisements, according to a congressional report....To view the full article, register now.
Already a subscriber? Click here to view full article